Why the Atlas Arteria (ASX:ALX) share price is falling today

The Atlas Arteria Group (ASX: ALX) share price is falling today after the company released a business update regarding COVID-19 restrictions.

| More on:
falling asx share price represented by cars driving along a broken arrow heading down

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Atlas Arteria Group (ASX: ALX) share price is falling in morning trade today after the company released a business update regarding COVID-19 movement restrictions. At the time of writing, the Atlas Arteria share price is sinking 1.47% to $6.72. In comparison, the S&P/ASX 200 Index (ASX: XJO) is marginally down 0.2% to 6,546 points.

Let's take a closer look at what is dragging the Atlas Arteria share price lower.

France

Recent lockdown measures taken by the French Government in late October resulted in softer traffic levels across the APRR network of roads. As COVID-19 cases continued to increase, the country entered a nation-wide lockdown in an attempt to halt community transmission of the virus. Essential businesses, such as factories, farms, construction sites, public administration offices, schools and childcare, remain open. People have been urged to work from home wherever possible and restrictions on movement is being enforced.

Despite the above, Atlas Arteria noted that traffic has been more resilient during the first two weeks of the second lockdown than when the pandemic first struck. In percentage terms, traffic is down roughly half of the reductions that were recorded in March and April. The company pointed out that November is seasonally one of the lowest traffic months for light vehicles on its roads.

Heavy vehicles using APRR's toll road networks is tracking along very well, matching Q3 performance.

Germany

Similar to its neighbour, Germany entered a 'lockdown light' for a period of four weeks in early November. The measures taken involve the restriction of private gatherings and the closure of all entertainment venues. As a result, traffic levels have experienced weaker demand, around 20% to 25% lower than 2019.

Atlas Arteria noted that the current lockdown isn't as strict as the earlier March-April lockdown in Germany.

United States

At the end of Q3, the company reported traffic at 44.8% below 2019 levels. However, in the past two weeks alone, traffic has been slowly improving to record at 40% below the same period last year.

Until recently, restrictions in Virginia had continued to relax from July 2020. Authorities have encouraged people to work from home, but schools and kindergartens have progressively opened.

Atlas Arteria share price summary

The Atlas Arteria share price has steadily been catching up to where it was in February, during which it reached an all-time high of $8.54. Currently trading at a discount of 21% to this high, Atlas Arteria has a market capitalisation of $6.4 billion.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »

Man with a hand on his head looks at a red stock market chart showing a falling share price.
Share Fallers

Why AIC Mines, ASX, Karoon Energy, and Life360 shares are falling today

These shares are falling more than most on Tuesday. But why?

Read more »

green lithium battery being held by person
Broker Notes

Forget Pilbara Minerals! Expert says this ASX lithium stock could soar 112%

Strategically important.

Read more »